Philip Hansbro, Deputy Director at the Centenary Institute and Professor John
Rasko AO, Head of the Centenary Institute’s Gene and Stem Cell Therapy Program
have both been awarded prestigious National Health and Medical Research Council
(NHMRC) Investigator Grants. The Investigator Grants scheme is one of the NHMRC’s
new flagship funding arrangements supporting outstanding health and medical
Philip Hansbro’s funding will support further research into the development of
new preventions and treatments for chronic respiratory diseases.
diseases are among the leading causes of all deaths world-wide,” says Professor
will fund our research into developing a comprehensive ‘molecular map’ for
specific respiratory diseases including Chronic Obstructive Pulmonary Disease
(COPD), lung cancer and severe asthma. This will increase our knowledge of how
these diseases develop and progress, providing us with new opportunities to
attempt treatments and cures.”
Rasko AO, Head of the Centenary Institute’s Gene and Stem Cell Therapy Program and
Head of Department, Cell
& Molecular Therapies at Royal Prince Alfred Hospital will
receive funding for his research focused on driving clinical cell and gene
therapy in Australia.
“Harnessing the power of our body’s own cells and genetic therapies, we are witnessing a medical revolution in curing serious diseases including hereditary bleeding and anaemia as well as specific forms of cancer. This new federal funding will facilitate our internationally acclaimed basic and clinical research Program designed to improve the health of Australians”, says Professor Rasko.
Read the full media release here.
Professor Phil Hansbro, Deputy Director and Faculty
at the Centenary Institute has been recognised for outstanding contributions to
the advancement of knowledge in respiratory medicine and science.
Professor Hansbro accepted the Research Medal at the Thoracic Society of Australia and New Zealand and Australian and New Zealand Society of Respiratory Science Annual Scientific Meeting (TSANZSRA) on the Gold Coast.
“It is a huge honour to receive this award. It means so much to me coming from this society. We have amongst us the best respiratory researchers in Australia and indeed the world. I attend the major respiratory conferences around the world and the quality and importance of the work that Australian researchers do is as good as anywhere and we certainly punch way way above our weight in Australia,” said Professor Hansbro on accepting the award at the Meeting’s Gala Dinner tonight.
Read the full Media Release.
Pictured: Dr Jacob Qi, Dr Renjing Liu and Professor Phil Hansbro.
The Centenary Institute would like to congratulate four of our researchers on securing funding under the Federal Government’s highly-competitive National Health and Medical Research Council’s (NHMRC) scheme.
Professor Phil Hansbro, Head of Centenary’s Centre for Inflammation, has been awarded a four-year Project Grant. His team will use the funding to develop new therapies for chronic obstructive pulmonary disease (COPD) – the third leading cause of death worldwide.
Dr Renjing Liu, Head of the Agnes Ginges Laboratory for Diseases of the Aorta in Centenary’s Vascular Biology Program, has been awarded two NHMRC project grants starting in 2019 to explore the role of epigenetics in cardiovascular diseases.
“Collaboration is key to successful research. The funding from NHMRC will allow me to continue my collaborations with leading researchers both nationally and abroad because improving human health is a global effort. It will also allow me to build a strong team to see that our work will contribute to increased understanding of biology and diseases, and add to making a difference in people’s lives,” says Dr Liu.
Dr Jacob Qi, also from Centenary’s Vascular Biology Program, has been awarded a three-year grant, which he will use to bolster his research into discovering the metabolic basis of non-alcoholic fatty liver disease progression to liver disease.
Dr Gerard Chu from Centenary’s Gene and Stem Cell Therapy Program, has been awarded a three-year Postgraduate Scholarship grant. Dr Chu’s research is focused on analysing the immune response and optimising the effectiveness of Mesothelin CAR T-Cell therapy in cancer.
Earlier this year, Centenary’s Professor Chris Semsarian, Associate Professor Jodie Ingles and Professor Warwick Britton were also awarded funding from the NHMRC. Read more about those grants here.